Martin Smrcina

Martin Smrcina is an experienced medicinal chemist currently serving as Executive Director of Medicinal Chemistry at Zafrens since November 2023. Prior roles include Associate Research Fellow at Icagen-Omniab Inc. and Icagen - Ligand Company, as well as Lead Research Investigator and Senior Researcher at Icagen. Martin's extensive background includes significant contributions at Sanofi as a Lead Research Investigator, focusing on projects related to diabetic complications, cancer, and inflammation. Academic credentials include a Ph.D. and Master's degree in Organic Chemistry from Charles University, along with postdoctoral training at Cornell University. Martin has led various research initiatives and developed innovative solutions for numerous therapeutic areas throughout a distinguished career.